Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diageo plc (DEO) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance

Diageo plcTrade
Nuvation Bio Inc. Class A Common StockTrade

Price performance (Past 24H)

Key statistics

Diageo plc vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Diageo plc trades at $86.72 (market cap $47.67B), while Nuvation Bio Inc. Class A Common Stock trades at $5.03 (market cap $1.74B). The key difference: Diageo plc is far larger — about 27.4× Nuvation Bio Inc. Class A Common Stock's market cap, and Diageo plc pays a 2.3% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Diageo plc for 66 Days and Nuvation Bio Inc. Class A Common Stock for 1 Days on average.

DEONUVB
Market Cap
$47.67B$1.74B
Volume
893,3729,289,619
Sector
Consumer StaplesHealth
52-Week High
$102.14$9.54
52-Week Low
$72.47$3.41
Typical Hold Time
66 Days1 Days
Enterprise Value
$68.09B$1.33B
Dividend Yield
2.3%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Diageo plc

Diageo (DEO) trades at $86.82, up 2.47% with bullish technical signals and strong analyst support. The stock shows solid fundamentals with consistent earnings beats, a 15.82% ROE, and improving cash flow trends. Recent corporate developments include a new CFO appointment and marketing initiatives supporting brand strength amid ongoing US business restructuring.

The outlook remains positive with 49% analyst buy ratings and cost-saving initiatives driving margin improvement. Key risks include US market volatility and regulatory challenges in India. The stock presents a compelling turnaround story with valuation support at current levels.

Nuvation Bio Inc. Class A Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Diageo plc

Diageo is a global leader in beverage alcohol with an outstanding collection of brands including Johnnie Walker, Smirnoff, and Guinness. It operates a vast portfolio of spirits and beers across more than 180 countries.

Read more on DEO →

About Nuvation Bio Inc. Class A Common Stock

Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.

Read more on NUVB →